Active Shortage Tablet Psychiatry

Amphetamine Aspartate Monohy · #22 of 35 active shortages by FDA posting duration

Name: FDA Drug Shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Creator: PlainMeds
License: https://plainmeds.com/terms

Compiled by PlainMeds, Drug Information Editorial Process

Brand: ADDERALL

FDA lists Amphetamine Aspartate Monohy as Active Shortage (Teva Pharmaceuticals USA, Inc.).

Availability on file: Available

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet: Active Shortage

Available 73 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Manufacturer: Teva Pharmaceuticals USA, Inc.
Dosage Form: Tablet
Presentation: Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)
Package NDC: 57844-117-01

Status & Timeline

Status: Active Shortage
Availability: Available
First Reported: Oct 12, 2022
Last Updated: Mar 16, 2026
Therapeutic Category: Psychiatry

Row fields from the FDA Drug Shortages database via openFDA.

Full Drug Profile

amphetamine/dextroamphetamine

Side effects, interactions, warnings & more

View Profile

Compare amphetamine/dextroamphetamine with alternatives →